Oxidized recombinant human growth hormone that maintains conformational integrity.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Pharmacy and Science

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/jps.22268PMID 20575051
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diketopiperazine formation and N-terminal degradation in recombinant human growth hormone.

  2009cited by this paper
• Effect of methionine oxidation of a recombinant monoclonal antibody on the binding affinity to protein A and protein G.

  2008cited by this paper
• Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation.

  2008cited by this paper
• Lehninger Principles of Biochemistry (5th edition)

  2008cited by this paper
• Fluorescence-based methods in the study of protein-protein interactions in living cells.

  2008cited by this paper
• Effects of protein oxidation on the structure and stability of model discoidal high-density lipoproteins.

  2008cited by this paper
• Raman spectroscopy of protein pharmaceuticals.

  2007cited by this paper
• Effects of oxidation on the structure and stability of human low-density lipoprotein.

  2007cited by this paper
• Detection and characterization of protein aggregates by fluorescence microscopy.

  2007cited by this paper
• Oxidation inhibits amyloid fibril formation of transthyretin

  2006cited by this paper
• Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.

  2005cited by this paper
• Sensitivity of polar solvation dynamics to the secondary structures of aqueous proteins and the role of surface exposure of the probe.

  2005cited by this paper
• Male Reproductive Toxicity of Trichloroethylene: Sperm Protein Oxidation and Decreased Fertilizing Ability1

  2004cited by this paper
• Clinical and Laboratory Investigations Increased advanced oxidation protein products in Behçet’s disease: a new activity marker?

  2004cited by this paper
• Bone metabolism in relation to alterations in systemic growth hormone.

  2004cited by this paper
• Analysis of protein interactions using fluorescence technologies.

  2003cited by this paper
• International Conference on Harmonisation; revised guidance on Q3B(R) Impurities in New Drug Products; Availability. Notice.

  2003cited by this paper
• Regulation of bone mass by growth hormone.

  2003cited by this paper
• Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution

  2003cited by this paper
• Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

  2002cited by this paper
• Fluorescence lifetime of Nile Red as a probe for the hydrogen bonding strength with its microenvironment

  2002cited by this paper
• Fluorescence polarization: analysis of carbohydrate-protein interaction.

  2001cited by this paper
• Administration of recombinant human growth hormone on alternate days is sufficient to increase whole body protein synthesis and lipolysis in growth hormone deficient adults

  2000cited by this paper
• Fluorescence quenching: A tool for single-molecule protein-folding study.

  2000cited by this paper
• Effect of conformation on the rate of deamidation of vancomycin in aqueous solutions.

  2000cited by this paper
• Separation of oxidized and deamidated human growth hormone variants by isocratic reversed-phase high-performance liquid chromatography.

  1999cited by this paper
• In Vitro Methionine Oxidation of Recombinant Human Leptin

  1998cited by this paper
• Loss of conformational stability in calmodulin upon methionine oxidation.

  1998cited by this paper
• Human growth hormone treatment of short-stature children born small for gestational age: effect on muscle and adipose tissue mass during a 3-year treatment period and after 1 year's withdrawal.

  1998cited by this paper
• Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance

  1998cited by this paper
• 1-Anilino-8-naphthalene sulfonate anion-protein binding depends primarily on ion pair formation.

  1998cited by this paper
• UV resonance Raman spectroscopy of DNA and protein constituents of viruses: assignments and cross sections for excitations at 257, 244, 238, and 229 nm.

  1998cited by this paper
• Structural and functional analysis of the 1:1 growth hormone:receptor complex reveals the molecular basis for receptor affinity.

  1998cited by this paper
• Hydrogen-Bond Acceptor and Donor Properties of Divalent Sulfur (Y-S-Z and R-S-H)

  1997cited by this paper
• Crystal Structure of an Antagonist Mutant of Human Growth Hormone, G120R, in Complex with Its Receptor at 2.9 Å Resolution*

  1996cited by this paper
• THE CRYSTAL-STRUCTURE OF WILD-TYPE GROWTH-HORMONE AT 2.5 ANGSTROM RESOLUTION.

  1995cited by this paper
• Oxidation of methionyl residues in proteins: tools, targets, and reversal.

  1995cited by this paper
• Human growth hormone.

  1994cited by this paper
• Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

  1992cited by this paper
• Separation of oxidized human growth hormone variants by reversed-phase high-performance liquid chromatography. Effect of mobile phase pH and organic modifier.

  1992cited by this paper
• Effect of protein conformation on rate of deamidation: Ribonuclease A

  1989cited by this paper
• Role of peptide conformation in the rate and mechanism of deamidation of asparaginyl residues.

  1988cited by this paper
• A reversed-phase high-performance liquid chromatographic method for characterization of biosynthetic human growth hormone.

  1987cited by this paper
• Methionine oxidation in human growth hormone and human chorionic somatomammotropin. Effects on receptor binding and biological activities.

  1987cited by this paper
• Nile red as a polarity-sensitive fluorescent probe of hydrophobic protein surfaces.

  1987cited by this paper
• Rotational freedom of tryptophan residues in proteins and peptides.

  1983cited by this paper
• Principles of fluorescence spectroscopy

  1983cited by this paper
• Biophysical Chemistry: Part II: Techniques for the Study of Biological Structure and Function

  1980cited by this paper
• Oxidation of the methionine residues of Escherichia coli ribosomal protein L12 decreases the protein's biological activity.

  1978cited by this paper
• Human somatotropin. Reaction with hydrogen peroxide.

  1977cited by this paper
• Selective oxidation of methionine residues in proteins.

  1975cited by this paper
• Selective tryptophan oxidation in the antitumor protein neocarzinostatin and effects on conformation and biological activity.

  1974cited by this paper
• Human pituitary growth hormone. 32. The primary structure of the hormone: revision.

  1971cited by this paper
• HUMAN GROWTH HORMONE

  1968cited by this paper

• Dissecting Methionine Oxidation by Hydrogen Peroxide in Proteins: Thermodynamics, Kinetics, and Susceptibility Descriptors

  2025cites this paper
• Design and synthesis of polyacrylic acid/deoxycholic acid-modified chitosan copolymer and a close inspection of human growth hormone-copolymer interactions: An experimental and computational study.

  2021cites this paper
• Evaluation of Super RefinedTM Polysorbate 20 with respect to Polysorbate Degradation, Particle Formation and Protein Stability.

  2020cites this paper
• Chemical Syntheses and Biological Evaluation of CXCL14 and Its Site-Selectively Modified Methionine Sulfoxide-Containing Derivatives.

  2019cites this paper
• Optical Detection of Degraded Therapeutic Proteins

  2018cites this paper
• Coupling of on-column trypsin digestion-peptide mapping and principal component analysis for stability and biosimilarity assessment of recombinant human growth hormone.

  2018cites this paper
• Porphyrin-polymer nanocompartments: singlet oxygen generation and antimicrobial activity

  2017cites this paper
• Influence of methionine oxidation on the aggregation of recombinant human growth hormone.

  2013cites this paper
• Oxidation of Therapeutic Proteins and Peptides: Structural and Biological Consequences

  2013cites this paper
• Methods for Characterizing Proteins in Aluminum Adjuvant Formulations

  2013cites this paper
• Effect of pH and Stirring Speed on the Collagenous Protein Extraction from Chicken Bone Waste in a Well Agitated Extraction System

  2012cites this paper
• Label-free differentiation of human pituitary adenomas by FT-IR spectroscopic imaging

  2012cites this paper
• Forced degradation of therapeutic proteins.

  2012cites this paper
• Methionine Sulfoxide Reductases Preferentially Reduce Unfolded Oxidized Proteins and Protect Cells from Oxidative Protein Unfolding*

  2012cites this paper
• Stability of human growth hormone: influence of methionine oxidation on thermal folding.

  2011cites this paper
• Excipient exchange in the comparison of preparations of the same biologic made by different manufacturing processes: an exploratory study with recombinant human growth hormone (rhGH).

  2010cites this paper
• Factors influencing conformation and physical stability of therapeutic proteins

  2010influential citation